Related Experiment Video
Updated: May 17, 2026

Isolation, Transfection, and Culture of Primary Human Monocytes
Published on: December 16, 2019
Shared monocyte subset phenotypes in HIV-1 infection and in uninfected subjects with acute coronary syndrome
Nicholas T Funderburg1, David A Zidar, Carey Shive
1Department of Medicine, Division of Infectious Diseases, Case Western Reserve University/University Hospitals of Cleveland, Cleveland, OH 44106, USA. NTF1@case.edu
Insights
HIV-1 infection alters monocyte subsets, increasing cardiovascular risk. Specific monocyte profiles in HIV-1 patients mirror those seen in acute coronary syndrome, suggesting shared inflammatory drivers.
Area of Science:
- Immunology
- Cardiovascular Medicine
- Virology
Background:
- The mechanisms linking human immunodeficiency virus type 1 (HIV-1) infection to increased cardiovascular risk are not fully understood.
- Monocyte subpopulations play a crucial role in immune responses and inflammation, potentially contributing to atherosclerosis.
Purpose of the Study:
- To investigate and compare the activation phenotypes of monocyte subpopulations in individuals with HIV-1 infection and those with acute coronary syndrome (ACS).
- To identify common cellular profiles that may explain the elevated cardiovascular risk in HIV-1 infection.
Main Methods:
- Flow cytometry was employed to analyze monocyte subpopulations (nonclassic and intermediate) and their activation markers (tissue factor, CD62P).
- Whole blood samples from HIV-1 infected individuals and ACS patients were compared to healthy controls.
- In vitro experiments exposed control blood to lipopolysaccharide (LPS) and HIV-1 to assess monocyte activation.
Main Results:
- HIV-1 infection is associated with a proportional increase in nonclassic (CD14(+)CD16(++)) and intermediate (CD14(++)CD16(+)) monocytes.
- These activated monocytes express high levels of tissue factor and CD62P, correlating with HIV-1 viral load, T-cell activation, and IL-6 levels.
- In vitro, HIV-1 selectively activated nonclassic monocytes, while LPS activated all subsets; the monocyte activation profile in uncontrolled HIV-1 disease resembles that of ACS.
Conclusions:
- Immune activation and inflammation in HIV-1 disease significantly alter monocyte subpopulations and their activation phenotypes.
- These alterations contribute to a pro-atherothrombotic state, thereby increasing cardiovascular risk in individuals with HIV-1 infection.
- The findings highlight potential therapeutic targets for mitigating cardiovascular complications in HIV-1 patients.
Abstract:
The mechanisms responsible for increased cardiovascular risk associated with HIV-1 infection are incompletely defined. Using flow cytometry, in the present study, we examined activation phenotypes of monocyte subpopulations in patients with HIV-1 infection or acute coronary syndrome to find common cellular profiles. Nonclassic (CD14(+)CD16(++)) and intermediate (CD14(++)CD16(+)) monocytes are proportionally increased and express high levels of tissue factor and CD62P in HIV-1 infection. These proportions are related to viremia, T-cell activation, and plasma levels of IL-6. In vitro exposure of whole blood samples from uninfected control donors to lipopolysaccharide increased surface tissue factor expression on all monocyte subsets, but exposure to HIV-1 resulted in activation only of nonclassic monocytes. Remarkably, the profile of monocyte activation in uncontrolled HIV-1 disease mirrors that of acute coronary syndrome in uninfected persons. Therefore, drivers of immune activation and inflammation in HIV-1 disease may alter monocyte subpopulations and activation phenotype, contributing to a pro-atherothrombotic state that may drive cardiovascular risk in HIV-1 infection.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome I: Introduction

